(AXNX) – Management Comments
-
Axonics Modulation Technologies (AXNX) Expands into Stress Urinary Incontinence with the Acquisition of Bulkamid
-
Axonics Modulation Technologies (AXNX) Granted FDA Approval for Third-Generation Implantable Neurostimulator
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AXNX Stock Lookup